Children's Hospital Association submitted comments on the cell and gene therapy request for information (RFI) from Sen. Bill Cassidy (R-La.), ranking member of the Senate Health, Education, Labor, and Pensions (HELP) Committee. Our response highlights the need to ensure children’s equitable access to these therapies and a strong national framework for payment and oversight.
CHA Response to Cell and Gene Therapy RFI
Cell and gene therapies have the potential to address unmet pediatric medical needs, reduce the need for costly chronic care, and help address health disparities.
Related Content
A New Blueprint for a Resilient Pediatric Supply Chain
CHA Leads Comments with Child Health Groups in Response to Proposed Rule
Protecting Children’s Access to Care: H.R. 1 Mitigation-Related Resources
A New Blueprint for a Resilient Pediatric Supply Chain
An unprecedented pilot public-private collaboration shows promise in mitigating drug shortages.
March 24, 2026
CHA Leads Comments with Child Health Groups in Response to Proposed Rule
Our joint comment letter highlights the implications for children’s health and children’s hospitals.
March 20, 2026
Protecting Children’s Access to Care: H.R. 1 Mitigation-Related Resources
H.R. 1 makes significant changes to the Medicaid program and includes policies that will limit children’s access to care.
March 20, 2026
